ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 201 filers reported holding ABCELLERA BIOLOGICS INC in Q4 2022. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $271,970 | +1211.1% | 59,124 | +1741.3% | 0.00% | – |
| Q2 2023 | $20,743 | -83.5% | 3,211 | -80.7% | 0.00% | – |
| Q1 2023 | $125,503 | -78.3% | 16,645 | -70.8% | 0.00% | -100.0% |
| Q4 2022 | $578,312 | +416.4% | 57,089 | +404.7% | 0.00% | – |
| Q3 2022 | $112,000 | -85.7% | 11,312 | -84.6% | 0.00% | -100.0% |
| Q2 2022 | $781,000 | -35.4% | 73,288 | -13.3% | 0.00% | 0.0% |
| Q4 2021 | $1,209,000 | +185.8% | 84,531 | +339.8% | 0.00% | 0.0% |
| Q2 2021 | $423,000 | – | 19,222 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $37,320,000 | 92.58% |
| Gruss & Co., LLC | 308,570 | $3,052,000 | 26.27% |
| Founders Fund Growth Management, LLC | 407,017 | $4,025,000 | 11.55% |
| Belmont Capital, LLC | 510,000 | $5,044,000 | 5.95% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $40,599,000 | 5.05% |
| GUARDIAN CAPITAL ADVISORS LP | 3,736,414 | $40,129,000 | 5.01% |
| Intellectus Partners, LLC | 1,091,505 | $10,795,000 | 3.84% |
| ArchPoint Investors | 617,213 | $6,104,000 | 2.49% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $563,000 | 1.85% |
| Casdin Capital, LLC | 1,650,000 | $16,319,000 | 1.07% |